What’s Next for AEQUUS PHARMACEUTICALS INC COMMON SHARES (OTCMKTS:AQSZF) After Having More Shares Shorted?

June 18, 2018 - By Richard Conner

The stock of AEQUUS PHARMACEUTICALS INC COMMON SHARES (OTCMKTS:AQSZF) registered an increase of 339.39% in short interest. AQSZF’s total short interest was 58,000 shares in June as published by FINRA. Its up 339.39% from 13,200 shares, reported previously. With 90,900 shares average volume, it will take short sellers 1 days to cover their AQSZF’s short positions. The short interest to AEQUUS PHARMACEUTICALS INC COMMON SHARES’s float is 0.11%.

The stock increased 3.09% or $0.0055 during the last trading session, reaching $0.1837. About 6,088 shares traded. Aequus Pharmaceuticals Inc. (OTCMKTS:AQSZF) has 0.00% since June 18, 2017 and is . It has underperformed by 12.57% the S&P500.

Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. The company has market cap of $13.57 million. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. It currently has negative earnings. The firm markets tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejection following organ transplantation; Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and topiramate and oxcarbazepine extended-release tablets for the treatment of epilepsy.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: